Stereoselective analysis of ritodrine diastereomers in human serum using HPLC

Journal of Chromatographic Science

Volumn 48, Issue 6, 2010, Pages 503-506

  Konda, Ainari ^a   Soma, Mayuko ^a   Ito, Taku ^a   Yakeuchi, Yuriko ^b   Toda, Takaki ^c   Hayakawa, Toru ^c   Inotsume, Nobuo ^c  

^a Tenshi Hospital   (Japan)

^b Kissei Pharamaceutical Industries   (Japan)

^c HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955484865     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/48.6.503     Document Type: Article

References (23)

1. S. N. Caritis, L. S. Lin, and L. K. Wong. Evaluation of the pharmacodynamics and pharmacokinetics of ritodrine when administered as a loading dose. On establishing a potentially useful drug administration regimen in cases of fetal distress. Am. J. Obstet. Gynecol. 15:1026-1031 (1985).
2. S. N. Caritis, R. Venkataramanan, M. Cotroneo, M. Smith, J. P. Chiao, and K. Habucky. Pharmacokinetics and pharmacodynamics of ritodrine after intramuscular administration to pregnant women. Am. J. Obstet. Gynecol. 162:1215-1219 (1990).
3. A. Konda, A. Nodai, M. Soma, Y. Koga, H. Yoshida, T. Toda, T. Hayakawa, and N. Inotsume. Ritodrine pharmacokinetics during a twin pregnancy. Eur. J. Clin. Pharmacol. in press.
4. R. A. O'Reilly. Studies on the optical enantiomorphs ofwarfarin in man. Clin. Pharmacol. Ther. 16:348-354 (1974).
5. I. Hayakawa, S. Atarashi, S. Yokohama, M. Imamura, K. Sakano, and M. Furukawa, Synthesis and antibacterial activities of optically active ofloxacin. Antimicrob. Agents Chemother. 29:163-164 (1986).
6. S. Narimatsu, M. Gotoh, Y. Masubuchi, T. Horie, S. Ohmori, M. Kitada, T. Kageyama, K. Asaoka, I. Yamamoto, and T. Suzuki. Stereoselectivity in bunitrolol 4-hydroxylation in liver microsomes from marmosets and Japanese monkeys. Biol. Pharm. Bull. 19:1429-1433 (1996).
7. T. de Boer, R. Bijma, and K. Ensing. Modeling of conditions for the enan-tiomeric separation of b2-adrenergic sympathicomimetics by capillary elec-trophoresis using cyclodextrins as chiral selectors in a polyethylene glycol gel. J. Pharmaceut. Biomed. Anal. 19:529-537 (1999).
8. N. L. Denola, N. S. Quiming, A. P. Catabay, Y. Saito, and K. Jinno. Optimization of capillary electrophoretic enantioseparation for basic drugs with native β-CD as a chiral selector. Electrophoresis 27:2367-2375 (2006).
9. N. Yamasaki, Y. Fukuda, Y. Shibazaki, T. Niizato, I. Kosugi, and S. Yoshioka. (-)-Ritodrine, therapeutic compositions and use, and method of preparation, US Patent 5449694 (1995).
10. E, Schiff, E. Sivan, S. Terry, M. Dulitzky, S. A. Friedman, S. Mashiach, and B. M. Sibai. Currenctly recommended oral regimens for ritodrine tocolysis result in extremely low plasma levels. Am. J. Obstet. Gynecol. 169:1059-1064 (1993).
11. Validation of compendial procedures in The United States Pharmacopeia, 30th ed., The United States P1harmacopeial Convention, Rockville, MD, 2007, pp. 680-83
12. S. N. Caritis, R. Venkataramanan, M. J. Darby, J. P. Chiao, and M. Krew. Pharmacokinetics of ritodrine administered intravenously: recommendations for changes in the current regimen. Am. J. Obstet. Gynecol. 162:429-437 (1990).
13. R. Gandar, L. W. de Zoeten, and J. B. van der Schoot. Serum level of ritodrine in man. Eur. J. Clin. Pharmacol. 17:117-122 (1980).
14. B. R. Kuhnert, T. L. Gross, P. M. Kuhnert, P. Erhard, and W. T. Brashar. Ritodrine pharmacokinetics. Clin. Pharmacol. Ther. 40:656-664 (1986).
15. L. S. Lin, S. N. Caritis, and L. K. Wong. Analysis of ritodrine in serum by high-performance liquid chromatography with electrochemical detection. J. Pharm. Sci. 73:131-133 (1984).
16. A. S. Gross, K. F. Brown, J. A. Baird-Lambert, and R. L. Nation. Determination of ritodrine in blood and plasma by high-performance liquid chromatog-raphy with fluorescence detection. J. Chromatogr. 15:400-408 (1987).
17. Z. Zhang, G. Yang, G. Liang, H. Liu, and Y. Chen. Chiral separation of tamusulosin isomers by HPLC using cellulose Tris (3, 5-dimethylphenylcar-bamate) as a chiral stationary phase. J. Pharmaceut. Biomed. Anal. 34:689-693 (2004).
18. C. Perrin, N. Matthijs, D. Mangelings, C. Granier-Loyaux, M. Mafttouh, D. I. Massart, and Y. Vander Heyden. Screening approach for chiral separation of pharmaceuticals Part II. Reversed-phase liquid chromatography. J. Chromatogr. A 966:119-134 (2002). (Pubitemid 34786602)
19. K. Tachibana and A. Ohnishi. Reversed-phase liquid chromatographic separation of enantiomers on polysaccharides type chiral stationary phases. J. Chromatogr. A 906:127-154 (2001).
20. E. J. Lee, K. Williams, R. Day, G. Graham, and D. Champion. Stereoselective disposition of ibuprofen enantiomers in man. Br. J. Clin. Pharmacol. 19:669-674 (1985).
21. G. Ding, Y. Liu, J. Sun, Y. Takeuchi, T. Toda, T. Hayakawa, S. Fukushima, S. Kishimoto, W. Lin, and N. Inotsume. Effect of absorption rate on pharma-cokinetics of ibuprofen in relation to chiral inversion in humans. J. Pharm. Pharmacol. 59:1509-1513 (2007).
22. T. Eriksson, S. Björkman, and P. Höglund. Clinical pharmacology of thalido-mide. Eur. J. Clin. Pharmacol. 57:365-376 (2001).
23. S. Murphy, F. M. Boyle, R. A. Davey, X-Q. Gu, and L. E. Mather. Enantioselectivity of thalidomide serum and tissue concentrations in a rat glioma model and effects of combination treatment with cisplatin and BCNU. J. Pharm. Pharmacol. 59:105-114 (2007).